$VERA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Vera Therapeutics, Inc.. Get notifications about new insider transactions in Vera Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | VERA | Vera Therapeutics, ... | Sofinnova Venture Partners X, ... | 10% Owner | Option Exercise | C | 0.00 | 2,187,504 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | Sofinnova Venture Partners X, ... | 10% Owner | Buy | P | 11.00 | 727,272 | 7,999,992 | 2,914,776 | 2.2 M to 2.9 M (+33.25 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | Sofinnova Venture Partners X, ... | 10% Owner | Buy | C | 0.00 | 2,187,504 | 0 | 2,187,504 | 0 to 2.2 M |
| May 18 2021 | VERA | Vera Therapeutics, ... | Longitude Capital Partners IV, ... | 10% Owner | Option Exercise | C | 0.00 | 2,187,504 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | Longitude Capital Partners IV, ... | 10% Owner | Buy | P | 11.00 | 909,090 | 9,999,990 | 3,096,594 | 2.2 M to 3.1 M (+41.56 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | Longitude Capital Partners IV, ... | 10% Owner | Buy | C | 0.00 | 2,187,504 | 0 | 2,187,504 | 0 to 2.2 M |
| May 18 2021 | VERA | Vera Therapeutics, ... | Katabi Maha | Director | Option Exercise | C | 0.00 | 2,187,504 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | Katabi Maha | Director | Buy | P | 11.00 | 727,272 | 7,999,992 | 2,914,776 | 2.2 M to 2.9 M (+33.25 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | Katabi Maha | Director | Buy | C | 0.00 | 2,187,504 | 0 | 2,187,504 | 0 to 2.2 M |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 818,984 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 100,526 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 423,642 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 818,984 | 0 | 1,343,152 | 524.2 K to 1.3 M (+156.24 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 100,526 | 0 | 524,168 | 423.6 K to 524.2 K (+23.73 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 423,642 | 0 | 423,642 | 0 to 423.6 K |
| May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 2,187,504 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Buy | P | 11.00 | 909,090 | 9,999,990 | 3,096,594 | 2.2 M to 3.1 M (+41.56 %) |
| May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 2,187,504 | 0 | 2,187,504 | 0 to 2.2 M |
| May 18 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Option Exercise | C | 0.00 | 17,488 | 0 | 0 | |
| May 18 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Buy | C | 0.00 | 17,488 | 0 | 17,488 | 0 to 17.5 K |
| May 17 2021 | VERA | Vera Therapeutics, ... | SEIDENBERG BETH C | Director | Option Exercise | A | 11.00 | 9,925 | 109,175 | 9,925 | |
| May 17 2021 | VERA | Vera Therapeutics, ... | Cheng Andrew | Director | Option Exercise | A | 11.00 | 9,925 | 109,175 | 9,925 | |
| May 17 2021 | VERA | Vera Therapeutics, ... | EMSTER KURT VON | Director | Option Exercise | A | 11.00 | 9,925 | 109,175 | 9,925 | |
| May 17 2021 | VERA | Vera Therapeutics, ... | Curley Joanne | Chief Development O ... | Option Exercise | A | 11.00 | 108,217 | 1,190,387 | 108,217 | |
| May 17 2021 | VERA | Vera Therapeutics, ... | Young Joseph R | SVP, Finance, Chief ... | Option Exercise | A | 11.00 | 13,722 | 150,942 | 13,722 | |
| May 17 2021 | VERA | Vera Therapeutics, ... | Fordyce Marshall | President and CEO | Option Exercise | A | 11.00 | 110,038 | 1,210,418 | 110,038 |
Page: 1